{"version":"1.0","provider_name":"Clinvest Research","provider_url":"https:\/\/clinvest.com\/es","title":"CGRP antibodies for the prevention of migraines - Clinvest Research","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"GSAWhWCDB6\"><a href=\"https:\/\/clinvest.com\/es\/cgrp-antibodies-for-the-prevention-of-migraines\/\">CGRP antibodies for the prevention of migraines<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/clinvest.com\/es\/cgrp-antibodies-for-the-prevention-of-migraines\/embed\/#?secret=GSAWhWCDB6\" width=\"600\" height=\"338\" title=\"&#8220;CGRP antibodies for the prevention of migraines&#8221; &#8212; Clinvest Research\" data-secret=\"GSAWhWCDB6\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/clinvest.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>","thumbnail_url":"https:\/\/clinvest.com\/wp-content\/uploads\/2021\/09\/antibodies.jpg","thumbnail_width":800,"thumbnail_height":400,"description":"As of October 2018, three antibodies that target an inflammatory protein which can trigger migraine attacks have been approved by the FDA for the treatment of Episodic and Chronic Migraine. This protein is called Calcitonin-Gene Related Peptide (CGRP)"}